Robert Jaffe | Investor Relations |
Tim Crew | Chief Executive Officer |
John Kozlowski | Chief Financial Officer |
Greetings and welcome to the Lannett Company Fiscal 2023 Second Quarter Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Robert Jaffe, Investor Relations for Lannett Company.
Good afternoon, everyone and thank you for joining us today to discuss Lannett Company’s fiscal 2023 second quarter financial results.
On the call today are Tim Crew, Chief Executive Officer; John Kozlowski, the company’s Chief Financial Officer; and Steve Lehrer, who leads our insulin biosimilar initiatives.